Back
iShares 10-20 Year Treasury Bond ETF Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
59
TLH
iShares 10-20 Year Treasury Bond ETF
Last Price:
110.87
Seasonality Move:
-0.58%
Sell
25
ALNY
Alnylam Pharmaceuticals
Last Price:
265.13
Seasonality Move:
5.61%
Buy
59
iShares 10-20 Year Treasury Bond ETF (TLH)
is a Buy
Is iShares 10-20 Year Treasury Bond ETF a Buy, Sell or Hold?
- The current iShares 10-20 Year Treasury Bond ETF [TLH] share price is $110.85. The Score for TLH is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- TLH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $265.27. The Score for ALNY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TLH Stock Price Chart
What is iShares 10-20 Year Treasury Bond ETF's stock price today?
-
The iShares 10-20 Year Treasury Bond ETF share price today is $110.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TLH is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $265.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
TLH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.07 | Buy |
| Relative Strength Index (14 RSI): | 65.56 | Buy |
| Chaikin Money Flow: | 169234 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (107.83 - 110.09) | Buy |
| Bollinger Bands (100): | (101.21 - 107.73) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 53.6 | Buy |
| Chaikin Money Flow: | 403934 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (256.2 - 277.22) | Sell |
| Bollinger Bands (100): | (158.9 - 265.08) | Buy |
TLH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.37 | Buy |
| 20-day SMA: | 109.25 | Buy |
| 50-day SMA: | 106.92 | Buy |
| 200-day SMA: | 104.4 | Buy |
| 8-day EMA: | 110.29 | Buy |
| 20-day EMA: | 109.29 | Buy |
| 50-day EMA: | 107.42 | Buy |
| 200-day EMA: | 105.04 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 256.17 | Buy |
| 20-day SMA: | 266.77 | Sell |
| 50-day SMA: | 258.27 | Buy |
| 200-day SMA: | 189.51 | Buy |
| 8-day EMA: | 260.57 | Buy |
| 20-day EMA: | 261.96 | Buy |
| 50-day EMA: | 250.03 | Buy |
| 200-day EMA: | 205.35 | Buy |
iShares 10-20 Year Treasury Bond ETF Earnings Growth & TLH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
iShares 10-20 Year Treasury Bond ETF Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||